CING
Cingulate Inc.$4.98-0.11 (-2.16%)Prev Close$5.09·MCap$29.5M·P/E—·Vol129.4K·Yield—
▲
Buys (12M)
5
$1.18M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$1.18M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Cingulate Inc. (CING) has been exclusively buying, with 5 insider purchases totaling $1.18M and 0 insider sales totaling $0.00. The most recent insider transaction was by Hargroves Thomas Jeffrey (director), who purchased $882.5K worth of shares on Jun 8, 2026. Cingulate Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $29.5M.
CING Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Hargroves Thomas Jeffrey | director | Buy | 175,097 | $5.04 | $882.5K3.1% OS | 97,468 |
| Feb 10, 2026 | Brams Matthew | officer: EVP and Chief Medical Officer | Buy | 3,502 | $5.04 | $17.7K | 4,656+303% |
| Feb 10, 2026 | Callahan Jennifer L. | officer: SVP and CFO | Buy | 8,755 | $5.04 | $44.1K | 5,059 |
| Feb 10, 2026 | Schaffer Shane J. | director, officer: Chief Executive Officer | Buy | 12,256 | $5.04 | $61.8K | 10,175 |
| Feb 10, 2026 | Werth Peter J. | director | Buy | 35,019 | $5.04 | $176.5K0.6% OS | 117,449+42% |
| Aug 15, 2024 | Myers Laurie | EVP and COO | Sell | 202 | $4.17 | $841.33 | 0 |
| Sep 15, 2023 | Callahan Jennifer L. | Corporate Controller | Buy | 5,000 | $0.67 | $3.3K | 0 |
| Aug 11, 2023 | Werth Peter J. | Director | Buy | 1,823,155 | $0.55 | $1.00M32.5% OS | 0 |
| May 12, 2023 | Callahan Jennifer L. | Corporate Controller | Buy | 6,000 | $1.06 | $6.3K | 0 |
| Dec 15, 2022 | Schaffer Shane J. | Chief Executive Officer | Buy | 10,000 | $1.02 | $10.2K | 0 |
| Dec 14, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 7,548 | $0.99 | $7.5K | 0 |
| Dec 13, 2022 | Schaffer Shane J. | Chief Executive Officer | Buy | 15,000 | $1.01 | $15.2K | 0 |
| Dec 13, 2022 | Werth Peter J. | Director | Buy | 28,934 | $0.98 | $28.4K0.5% OS | 0 |
| Nov 28, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 5,017 | $0.98 | $4.9K | 0 |
| Nov 23, 2022 | Gilgallon Craig S. | EVP, GC and Secretary | Buy | 3,575 | $0.84 | $3.0K | 0 |
| Nov 23, 2022 | Myers Laurie | EVP and COO | Buy | 1,111 | $0.90 | $999.68 | 0 |
| Nov 22, 2022 | GIVENS GREGG WM | Director | Buy | 85,000 | $0.88 | $74.9K1.5% OS | 0 |
| Sep 8, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 3,500 | $1.50 | $5.2K | 0 |
| Sep 6, 2022 | Werth Peter J. | Director | Buy | 74,500 | $1.52 | $113.2K1.3% OS | 0 |
| Sep 1, 2022 | Myers Laurie | EVP and COO | Buy | 636 | $1.57 | $999.47 | 0 |
| Jun 1, 2022 | Myers Laurie | EVP and COO | Buy | 200 | $1.18 | $236.38 | 0 |
| May 17, 2022 | Myers Laurie | EVP and COO | Buy | 200 | $1.21 | $241.58 | 0 |
| May 6, 2022 | Medeiros Curtis | Director | Sell | 17,532 | $1.27 | $22.2K | 0 |
| Mar 17, 2022 | Werth Peter J. | Director | Buy | 27,000 | $1.79 | $48.3K | 0 |
| Mar 16, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 1,900 | $1.39 | $2.6K | 0 |
| Mar 16, 2022 | Myers Laurie | EVP and COO | Buy | 353 | $1.40 | $494.13 | 0 |
| Mar 15, 2022 | Callahan Jennifer L. | SVP and CFO | Buy | 55 | $27.10 | $1.5K | 0 |
| Mar 14, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 12,000 | $1.46 | $17.5K | 0 |
| Mar 14, 2022 | Gilgallon Craig S. | EVP & General Counsel | Buy | 5,975 | $1.38 | $8.2K | 0 |
| Mar 14, 2022 | GIVENS GREGG WM | Director | Buy | 56,000 | $1.35 | $75.7K1.0% OS | 0 |
| Mar 14, 2022 | Medeiros Curtis | Director | Buy | 17,532 | $1.41 | $24.8K | 0 |
| Mar 14, 2022 | VAN HORN LOUIS G | EVP and CFO | Buy | 15,000 | $1.34 | $20.0K | 0 |
CING Insider Buying Activity
The following table shows recent insider purchases of Cingulate Inc. (CING) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Hargroves Thomas Jeffrey | director | Buy | 175,097 | $5.04 | $882.5K3.1% OS | 97,468 |
| Feb 10, 2026 | Brams Matthew | officer: EVP and Chief Medical Officer | Buy | 3,502 | $5.04 | $17.7K | 4,656+303% |
| Feb 10, 2026 | Callahan Jennifer L. | officer: SVP and CFO | Buy | 8,755 | $5.04 | $44.1K | 5,059 |
| Feb 10, 2026 | Schaffer Shane J. | director, officer: Chief Executive Officer | Buy | 12,256 | $5.04 | $61.8K | 10,175 |
| Feb 10, 2026 | Werth Peter J. | director | Buy | 35,019 | $5.04 | $176.5K0.6% OS | 117,449+42% |
| Sep 15, 2023 | Callahan Jennifer L. | Corporate Controller | Buy | 5,000 | $0.67 | $3.3K | 0 |
| Aug 11, 2023 | Werth Peter J. | Director | Buy | 1,823,155 | $0.55 | $1.00M32.5% OS | 0 |
| May 12, 2023 | Callahan Jennifer L. | Corporate Controller | Buy | 6,000 | $1.06 | $6.3K | 0 |
| Dec 15, 2022 | Schaffer Shane J. | Chief Executive Officer | Buy | 10,000 | $1.02 | $10.2K | 0 |
| Dec 14, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 7,548 | $0.99 | $7.5K | 0 |
| Dec 13, 2022 | Schaffer Shane J. | Chief Executive Officer | Buy | 15,000 | $1.01 | $15.2K | 0 |
| Dec 13, 2022 | Werth Peter J. | Director | Buy | 28,934 | $0.98 | $28.4K0.5% OS | 0 |
| Nov 28, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 5,017 | $0.98 | $4.9K | 0 |
| Nov 23, 2022 | Gilgallon Craig S. | EVP, GC and Secretary | Buy | 3,575 | $0.84 | $3.0K | 0 |
| Nov 23, 2022 | Myers Laurie | EVP and COO | Buy | 1,111 | $0.90 | $999.68 | 0 |
| Nov 22, 2022 | GIVENS GREGG WM | Director | Buy | 85,000 | $0.88 | $74.9K1.5% OS | 0 |
| Sep 8, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 3,500 | $1.50 | $5.2K | 0 |
| Sep 6, 2022 | Werth Peter J. | Director | Buy | 74,500 | $1.52 | $113.2K1.3% OS | 0 |
| Sep 1, 2022 | Myers Laurie | EVP and COO | Buy | 636 | $1.57 | $999.47 | 0 |
| Jun 1, 2022 | Myers Laurie | EVP and COO | Buy | 200 | $1.18 | $236.38 | 0 |
| May 17, 2022 | Myers Laurie | EVP and COO | Buy | 200 | $1.21 | $241.58 | 0 |
| Mar 17, 2022 | Werth Peter J. | Director | Buy | 27,000 | $1.79 | $48.3K | 0 |
| Mar 16, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 1,900 | $1.39 | $2.6K | 0 |
| Mar 16, 2022 | Myers Laurie | EVP and COO | Buy | 353 | $1.40 | $494.13 | 0 |
| Mar 15, 2022 | Callahan Jennifer L. | SVP and CFO | Buy | 55 | $27.10 | $1.5K | 0 |
| Mar 14, 2022 | Callahan Jennifer L. | Corporate Controller | Buy | 12,000 | $1.46 | $17.5K | 0 |
| Mar 14, 2022 | Gilgallon Craig S. | EVP & General Counsel | Buy | 5,975 | $1.38 | $8.2K | 0 |
| Mar 14, 2022 | GIVENS GREGG WM | Director | Buy | 56,000 | $1.35 | $75.7K1.0% OS | 0 |
| Mar 14, 2022 | Medeiros Curtis | Director | Buy | 17,532 | $1.41 | $24.8K | 0 |
| Mar 14, 2022 | VAN HORN LOUIS G | EVP and CFO | Buy | 15,000 | $1.34 | $20.0K | 0 |
CING Insider Selling Activity
The following table shows recent insider sales of Cingulate Inc. (CING) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 15, 2024 | Myers Laurie | EVP and COO | Sell | 202 | $4.17 | $841.33 | 0 |
| May 6, 2022 | Medeiros Curtis | Director | Sell | 17,532 | $1.27 | $22.2K | 0 |
CING Insiders
Similar Stocks to CING
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B